| 영문 | plasma | 한글 | 혈장 |
|---|---|---|---|
| 설명 | 혈액이나 림프액의 액체 부분을 말하는데, 주로 혈액에서 고형성분(혈구세포)을 제외한 액체 부분을 의미한다. 여기에는 단백성분(면역현상을 유발하는 항체를 포함함), 영양성분(각 세포에 영양분을 공급함), 그리고 혈액응고 성분(상처가 났을 때 출혈이 멎을 수 있도록 함) 등이 포함된다. |
||
| 영문 | plasma membrane | 한글 | 형질막 |
|---|---|---|---|
| 설명 | 원형질 표면을 덮는 엷은막. 두께는 5~25μm이다. 광학현미경으로는 관찰할 수 없지만 전자현미경으로 관찰이 가능하다. 원형질막의 분자구조는 레시틴이나 콜레스테롤 등의 표면 활성물질 분자가 2분자층으로 그 표면에 배열되며, 이것을 각 1분자층의 단백질 분자가 양쪽에서 샌드위치한 단위막 구조이다. 전자현미경적으로 이 단위는 암-명-암의 3층(각 약 20nm)으로 구별된다. 원형질의 투과성에 중요한 구실을 하며, 생리상태가 변하면 그 투과성도 신속히 변한다. 또, 손상이 되면 쉽게 새로 형성된다. |
||
| LEOPARD | lentigines, EKG abnormalities, ocular hypertelorism, pulmonary stenosis, abnormalities of genitalia,... |
|---|---|
| SCARF | skeletal abnormalities, cutis laxa, craniostenosis, psychomotor retardation, facial abnormalities [s... |
| VACTERL | vertebral abnormalities, anal atresia, cardiac abnormalities, tracheoesophageal fistula and/or esoph... |
| LP | labile peptide; labile protein; laboratory procedure; lactic peroxidase; lamina propria; laryngophar... |
| FENa, FeNa | Fractional Excretion of Sodium ; Volume의 개념을 제거하여 좀 더 정확한 신장의 농축 능력을 평가, &n... |
| RWMA | Regional Wall Motion Abnormalities |
|---|---|
| A | abnormalities |
| %WMA | wall motion abnormalities |
| LDL-C | lipoprotein cholesterol and low-density lipoprotein cholesterol |
| LPDP | Lipoprotein-deficient plasma |
| abnormalities | Congenital malformations of organs or parts. (12 Dec 1998) |
|---|---|
| abnormalities, drug-induced | Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment. (12 Dec 1998) |
| abnormalities, radiation-induced | Congenital changes in the morphology of organs produced by exposure to ionizing or non-ionizing radiation. (12 Dec 1998) |
| atrioventricular conduction abnormalities | <cardiology, physiology> Any condition which involves abnormal (blocked, delayed or aberrant) electrical conduction through the atrioventricular node (for example atrioventricular block). Some medications may precipitate atrioventricular conduction abnormalities. (02 Jan 1998) |
| A-V conduction abnormalities | <cardiology, physiology> Any condition which involves abnormal (blocked, delayed or aberrant) electrical conduction through the atrioventricular node (for example atrioventricular block). Some medications may precipitate atrioventricular conduction abnormalities. (02 Jan 1998) |
| cardiovascular abnormalities | Congenital structural abnormalities of the cardiovascular system. (12 Dec 1998) |
| maxillofacial abnormalities | Congenital structural deformities, malformations, or other abnormalities of the maxilla and face or facial bones. (12 Dec 1998) |
| respiratory system abnormalities | Congenital structural abnormalities of the respiratory system. (12 Dec 1998) |
| chromosome abnormalities | Defects in the structure or number of chromosomes resulting in structural aberrations or manifesting as disease. (12 Dec 1998) |
| mouth abnormalities | Congenital absence of or defects in structures of the mouth. (12 Dec 1998) |
| congenital kidney abnormalities | Kidney abnormalities that are present from birth (for example polycystic kidneys). (27 Sep 1997) |
| musculoskeletal abnormalities | Congenital structural abnormalities and deformities of the musculoskeletal system. (12 Dec 1998) |
| craniofacial abnormalities | Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones. (12 Dec 1998) |
| skin abnormalities | Congenital structural abnormalities of the skin. (12 Dec 1998) |
| neonatal diseases and abnormalities | Diseases existing at birth and often before birth, regardless of causation. Of these congenital diseases, those characterised by structural deformities are termed abnormalities. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|